University of Massachusetts, Lowell

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, University of Massachusetts, Lowell sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials 1 currently recruiting 7 completed top decile by trial count

University of Massachusetts, Lowell: 9 sponsored US clinical trials, 1 recruiting.

University of Massachusetts, Lowell sponsors 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 7 completed. The most-studied condition in this pipeline is Cardiovascular Risk Factor, with 1 trials.

Top-decile sponsor footprint

University of Massachusetts, Lowell ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

9 total, page 1 of 1

RECRUITING NA

Enjoying Affordable and Tasty Food Together

NCT07036757
COMPLETED

The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health

NCT05864352
COMPLETED NA

VR Cognitive Rehabiliation for Pediatric TBI

NCT04526639
COMPLETED NA

Reducing Head Impact Exposure in Hawaii High School Football

NCT04020874
TERMINATED NA

Yogurt Supplementation to Alter Bone Biomarkers, the Gut Microbiota and Inflammation in Older Adults

NCT05350579
COMPLETED NA

Effects of a 12-week Home-based Yoga on Bone and Cardiovascular Health

NCT04353700
COMPLETED NA

VR-based EF Rehabilitation for Pediatric TBI

NCT03611062
COMPLETED NA

Video Game-based Therapy for Arm Weakness In Progressive Multiple Sclerosis

NCT03094364
COMPLETED

Boston Puerto Rican Health Study

NCT01231958

Therapeutic Areas

Cardiovascular Risk Factor 1
Osteoporosis 1
TBI (Traumatic Brain Injury) 1

What is open in the University of Massachusetts, Lowell pipeline

1 recruiting of 9 indexed (11% open); 7 completed (78%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Cardiovascular Risk Factor (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Massachusetts, Lowell: open-pipeline peers nationwide

Peers matched on 9 registered trials and 11% open enrollment, not the therapeutic-area sidebar.

University of Massachusetts, Lowell sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%10%20%30%40%50% Total trials Recruiting share University of Massachusetts, Lowell4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi companyADC Therapeutics S.A.Adrian VellaAIDS Malignancy ConsortiumAmylyx Pharmaceuticals
University of Massachusetts, Lowell sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Massachusetts, Lowell sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 trials (± recruiting share)

Sponsors near 11% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Massachusetts, Lowell page

9 registered trials is a research-attention snapshot, not an endorsement of University of Massachusetts, Lowell or any single study.

  • 1 of University of Massachusetts, Lowell's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cardiovascular Risk Factor is the condition University of Massachusetts, Lowell studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cardiovascular Risk Factor trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Massachusetts, Lowell pipeline card: 9 registered trials from official public datasets.Report a data error.